AnalystsGeoff PorgesGeoff Porges's Stock Forecasts
AnalystsGeoff Porges
Analyst Ranking
Top 27%
#1223 out of 4565 analysts
Average Return
+1.88%
Win Rate
47%37 out of 79
Risk vs Reward
Poor
Good
Geoff Porges's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pandion Therapeutics IncPAND | +219.36% | $18.85 | $60.20 | 2020-08-10 - 2021-02-26 | Buy |
Epizyme IncEPZM | +183.33% | $8.40 | $23.80 | 2019-01-06 - 2020-01-07 | Buy |
Arcus Biosciences IncRCUS | +72.22% | $20.27 | $34.91 | 2020-11-05 - 2021-11-05 | Buy |
Alexion Pharmaceuticals IncALXN | +48.48% | $102.49 | $152.18 | 2020-07-30 - 2021-03-23 | Buy |
Theravance Biopharma IncTBPH | +46.50% | $6.86 | $10.05 | 2021-09-15 - 2022-09-15 | Buy |
Geoff Porges Analyst Color
Get additional color on Geoff Porges's coverage of popular stocks
Geoff Porges's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pfizer IncPFE | 10 | Hold | $56.00 | N/A | Maintains | 2 years ago |
Radius Health IncRDUS1 | 9 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Arcus Biosciences IncRCUS | 6 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 11 | Buy | $850.00 | N/A | Maintains | 2 years ago |
Halozyme Therapeutics IncHALO | 2 | Buy | $48.00 | N/A | Maintains | 2 years ago |
Amgen IncAMGN | 10 | Hold | $216.00 | N/A | Maintains | 2 years ago |
Abbvie IncABBV | 12 | Buy | $135.00 | N/A | Maintains | 2 years ago |
Roivant Sciences LtdROIV | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Gilead Sciences IncGILD | 11 | Buy | $75.00 | N/A | Maintains | 2 years ago |
Acceleron Pharma IncXLRN | 5 | Hold | $180.00 | N/A | Maintains | 3 years ago |
SanofiSNY | 2 | Buy | N/A | N/A | Upgrades | 3 years ago |
Theravance Biopharma IncTBPH | 9 | Buy | $10.00 | N/A | Maintains | 3 years ago |
Fibrogen IncFGEN | 5 | Buy | $30.00 | N/A | Maintains | 3 years ago |
Translate Bio IncTBIO1 | 6 | Hold | $38.00 | N/A | Maintains | 3 years ago |
Vertex Pharmaceuticals IncVRTX | 8 | Sell | $175.00 | N/A | Maintains | 3 years ago |
Morphosys AgMOR | 2 | Buy | N/A | N/A | Upgrades | 3 years ago |
Assembly Biosciences IncASMB | 3 | Hold | $84.00 | N/A | Maintains | 3 years ago |
Alexion Pharmaceuticals IncALXN | 6 | Hold | $156.00 | N/A | Downgrades | 3 years ago |
Pandion Therapeutics IncPAND | 2 | Hold | $60.00 | N/A | Downgrades | 3 years ago |
Opthea LtdOPT | 1 | Buy | $33.00 | N/A | Initiates Coverage On | 3 years ago |
Principia Biopharma IncPRNB | 1 | Hold | $100.00 | N/A | Downgrades | 4 years ago |
Epizyme IncEPZM | 5 | Buy | N/A | N/A | Upgrades | 5 years ago |
Wave Life Sciences LtdWVE | 2 | Buy | $61.00 | N/A | Initiates Coverage On | 5 years ago |
Dova Pharmaceuticals IncDOVA | 2 | Hold | $31.00 | N/A | Maintains | 6 years ago |
Celgene CorpCELG | 1 | Buy | $160.00 | N/A | Maintains | 7 years ago |
Biogen IncBIIB | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.